The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Due to the recent changes in the indication to allogeneic stem cell transplantation (SCT) in chronic myeloid leukemia (CML), we retrospectively analyzed 1,716 patients with different CML stages who received an allograft from related (n = 767) or unrelated donors (n = 938) within the German Registry of Stem Cell Transplantation (DRST) from 1998 to 2004. Myeloablative conditioning was performed in 724/871 cases (83%), dose-reduced conditioning in 147/871 (17%). Annual transplantations were decreasing from 357 to 98 (28%) in the period of study, but the proportion of advanced cases was increasing from 32% (112/346) to 53% (50/94) of all SCTs. Stage of disease, intervals from diagnosis, and patients' age were independent prognostic parameters, while peripheral stem cells and unrelated transplantation seemed equal to bone marrow/related transplantation. This study demonstrates that allo-SCT still has an important role in advanced CML, which emphasizes the need for optimized transplantation strategies for these high-risk patients.
Bacher
Ulrike
U
Interdisziplinäre Klinik für Stammzelltransplantation, Universitäres Cancer Center Hamburg (UCCH), Martinistr. 52, 20246 Hamburg, Germany. u.bacher@uke.de
Klyuchnikov
Evgeny
E
Zabelina
Tatjana
T
Ottinger
Hellmut
H
Beelen
Dietrich W
DW
Schrezenmeier
Hubert
H
Ehninger
Gerhard
G
Müller
Carlheinz
C
Berger
Jürgen
J
Suttorp
Meinolf
M
Kolb
Hans-Jochem
HJ
Kröger
Nicolaus
N
Zander
Axel R
AR